Your session is about to expire
← Back to Search
Elly Mobile Phone Application for Pancreatic Cancer
N/A
Waitlist Available
Led By Gillian Gresham, PhD
Research Sponsored by Gillian Gresham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of cancer of any type and currently receiving cancer-targeted treatment or have received cancer-targeted treatment within 6 months of consent date based on self-report. Cancer-targeted treatment includes chemotherapy, radiation therapy, hormonal therapy, biologic therapy, immunotherapy, and surgery.
18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 360
Awards & highlights
Study Summary
This study is evaluating whether a mobile health application may help reduce anxiety, stress, loneliness, and social isolation for cancer survivors and patients.
Eligible Conditions
- Pancreatic Cancer
- Stress
- Head and Neck Cancers
- Tumors
- Bladder Cancer
- Glioblastoma
- Anxiety
- Melanoma
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Sarcoma
- Lung Cancer
- Gynecologic Cancers
- Cancer
- Kidney Cancer
- Lymphoma
- Social Isolation
- Loneliness
- Uterine Cancer
- Leukemia
- Multiple Myeloma
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 360
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 360
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Anxiety
Secondary outcome measures
Absolute change in patient-reported anxiety scores at Day 120 compared with baseline.
Absolute change in patient-reported anxiety scores at Day 14 compared with baseline.
Absolute change in patient-reported anxiety scores at Day 150 compared with baseline.
+26 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Elly Mobile Phone ApplicationExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Gillian GreshamLead Sponsor
Gillian Gresham, PhDPrincipal Investigator - Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
3 Previous Clinical Trials
140 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger